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Summary
The antagonistic pleiotropy (AP) theory posits that aging occurs
because alleles that are detrimental in older organisms are
beneficial to growth early in life and thus are maintained in
populations. Although genes of the insulin signaling pathway
likely participate in AP, the insulin-regulated cellular correlates of
AP have not been identified. The mitochondrial quality control
process called mitochondrial autophagy (mitophagy), which is
inhibited by insulin signaling, might represent a cellular correlate
of AP. In this view, rapidly growing cells are limited by ATP
production; these cells thus actively inhibit mitophagy to max-
imize mitochondrial ATP production and compete successfully for
scarce nutrients. This process maximizes early growth and
reproduction, but by permitting the persistence of damaged
mitochondria with mitochondrial DNA mutations, becomes detri-
mental in the longer term. I suggest that as mitochondrial ATP
output drops, cells respond by further inhibiting mitophagy,
leading to a further decrease in ATP output in a classic death
spiral. I suggest that this increasing ATP deficit is communicated
by progressive increases in mitochondrial ROS generation, which
signals inhibition of mitophagy via ROS-dependent activation of
insulin signaling. This hypothesis clarifies a role for ROS in aging,
explains why insulin signaling inhibits autophagy, and why cells
become progressively more oxidized during aging with increased
levels of insulin signaling and decreased levels of autophagy. I
suggest that the mitochondrial death spiral is not an error in cell
physiology but rather a rational approach to the problem of
enabling successful growth and reproduction in a competitive
world of scarce nutrients.
Key words: aging; Foxo; insulin signaling; mitophagy; reac-
tive oxygen species; Tor.
In the long run we are all dead. Economists set
themselves too easy, too useless a task, if in tempes-
tuous seasons they can only tell us, that when the
storm is long past, the ocean is flat again.John
Maynard Keynes, 1923
The death spiral, pros and cons
A death spiral, also known as a vicious circle, is a specific form of positive
feedback in which steps taken to handle a particular problem, while
successful in the short term, exacerbate the problem in the long term.
The classic example of a death spiral is a company with debt trouble that
must borrow to pay for operating expenses. Although the operating
expenses can get paid (short-term success), the additional borrowing
worsens the company’s debt problem (long-term exacerbation).
Insurance companies can face death spirals when, as a consequence
of adverse selection, claims increase unexpectedly, which necessitate
premium increases, which increase the adverse selection, etc.
The death spiral is generally viewed unfavorably because the end
result of a death spiral is generally catastrophic failure. However, in
comparison with the alternative, the death spiral offers critical advan-
tages. For example, when a debt-afflicted company borrows money to
pay operating costs, it survives longer – perhaps not forever, but longer
at least than it would have in the absence of this activity. Reaping
benefits in the long term first requires survival through the short term, as
is indicated above in the quote from John Maynard Keynes, and the
death spiral can, at least, promote this short-term survival.
Aging as a form of death spiral
From an evolutionary perspective, aging has been difficult to under-
stand. Natural selection increases organismal fitness, and yet aging,
which clearly decreases fitness, is not only observed, but also appears to
be nearly universal within multicellular (and even some single-celled)
organisms. To address this dilemma, it was proposed that aging occurs
and is fixed in populations because alleles that have deleterious effects in
old age benefit growth, survival, and reproduction in youth. This theory
is called antagonistic pleiotropy (AP) theory (Williams, 1957). In this view,
aging occurs because alleles that in the short term are beneficial in
solving problems in growth and reproduction serve to exacerbate the
problem in the long run. Therefore, aging can be viewed as a form of
death spiral.
Evidence that the genes of the insulin signaling (IIS)
pathway mediate AP
If this premise is accepted, the next step is to identify the alleles that
mediate AP, understand the nature of these alleles, how they might
exert AP, and finally identify and define the critical cellular processes
affected by AP.
Alleles of genes in the insulin/insulin growth factor signaling (IIS)
pathway are the likeliest candidates for AP alleles (Walker et al., 2000;
Blagosklonny, 2010). Loss-of-function alleles in the IIS pathway slow
aging and increase lifespan in a variety of invertebrate and vertebrate
systems (Kenyon, 2010), which means that wild-type alleles of the IIS
pathway promote aging and decrease lifespan. In C. elegans, loss-of-
function alleles in the insulin receptor (daf-2), PI3K (age-1) and Akt (two
redundant genes, in double mutant), the D. melanogaster insulin
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receptor InR and insulin receptor substrate chico, and the mouse growth
hormone-releasing hormone gene GHRH and the insulin growth factor
receptor IGFR1 each delay aging (Clancy et al., 2001; Flurkey et al.,
2002; Holzenberger et al., 2003; Kenyon, 2010). Thus, wild-type alleles
of this pathway, by promoting aging and impairing longevity, fulfill the
requirement that AP alleles are deleterious to organisms in old age. In
addition, members of the Foxo transcription factor family, which are
inhibited by IIS, slow aging in a number of systems (Martins et al., 2016).
IIS genes also fulfill the requirement that AP alleles promote growth
and reproduction at young ages. Loss-of-function mutations in IIS genes
confer many deleterious effects to young organisms, including very slow
growth, dwarfism, and deficient fecundity. It is unlikely that such
mutants could reproduce or even survive in the wild. Taken together,
these results indicate that wild-type alleles of the IIS pathway promote
growth and reproduction in young organisms at the expense of rapid
aging.
IIS pathway activity increases protein translation
and inhibits autophagy
The accelerated aging by IIS pathway activity is most likely mediated by
one or more of the cellular outputs regulated by IIS. These outputs
include autophagy, which is inhibited by IIS, and cell growth, which is
activated by IIS (Kapahi et al., 2010). Two molecular targets of IIS that
regulate each include the Tor kinase (Schmelzle & Hall, 2000), which is
activated by IIS (Hay & Sonenberg, 2004), and the Foxo transcription
factor, which is inhibited by IIS (Tang et al., 1999; Fig. 1). Both Tor and
Foxo have been implicated in mediating the effects of IIS on aging; Foxo
activity promotes longevity and Tor activity promotes aging (Kenyon,
2010). Consistent with these observations, Tor and Foxo regulate a
strongly overlapping series of outputs, but in opposite directions. Tor
inhibits autophagy by directly phosphorylating and inhibiting critical
autophagy proteins such as ATG13 (Kamada et al., 2010) while
simultaneously promoting protein synthesis by phosphorylating and
inhibiting the translation inhibitor 4E-BP (Hay & Sonenberg, 2004; Kim
et al., 2011; Fig. 1). In contrast, Foxo activates autophagy by activating
transcription of autophagy genes ATG8 and ATG12while simultaneously
inhibiting protein synthesis by activating 4E-BP transcription (J€unger
et al., 2003; Webb & Brunet, 2014; Fig. 1). These effects of Tor and
Foxo on autophagy components are physiologically significant. Tor
activation decreases autophagy (Kim et al., 2011), whereas loss of Foxo
decreases autophagy in muscle and other tissues (Mammucari et al.,
2007).
Autophagy is likely to be an important process for control of aging
(Rubinsztein et al., 2011; Tower, 2015). As a quality control mechanism
that ensures adequate function of proteins and organelles over time,
autophagy would enable cells to maintain viability over long periods.
Indeed, inhibiting autophagy confers cellular deficits related to aging
(Blagosklonny, 2010; Rubinsztein et al., 2011). Furthermore, autophagy
declines during normal aging in Drosophila muscle (Demontis &
Perrimon, 2010), mouse lung (Shirakabe et al., 2016), and human brain
(Lipinski et al., 2010), and the mitochondrial autophagy (mitophagy)
inducer PINK1 is transcriptionally downregulated during aging in mouse
lung (Sosulski et al., 2015). It was previously proposed that IIS pathway
activity is deleterious to old organisms via inhibition of autophagy
(Blagosklonny, 2010; Gems & de la Guardia, 2012).
Although autophagy is responsible for degrading many types of
damaged organelles or other macromolecular structures, mitophagy is
likely to be the process most critical for aging. First, an early theory of
aging posited that cellular damage caused by free radicals or reactive
oxygen species (ROS; Harman, 1956) is a major cause of aging. ROS
chemically modify a number of different functional groups on proteins,
lipid, and DNA and thereby cause dysfunction. Mitochondria are a
potent source of ROS generation and therefore would be expected to be
particularly susceptible to ROS-mediated damage. Second, alone among
organelles and other macromolecular structures within animal cells,
mitochondria possess DNA, which encodes several proteins critical for
oxidative phosphorylation. Whereas every other macromolecular struc-
ture can be perfectly reconstructed with only nuclear genomic input,
mitochondria are uniquely dependent on non-nuclear DNA for contin-
ued activity. Thus, ROS-mediated mitochondrial DNA damage, if allowed
to persist, irreversibly impairs mitochondrial function. With time, the
continuous accumulation of mitochondrial DNA mutations would
continuously ratchet down mitochondrial ATP productive capacity, and
be primarily responsible for the decline in cellular function over time.
IIS inhibits mitochondrial quality control by
inhibiting mitophagy
Cells possess numerous mechanisms to enable maintenance of mito-
chondrial function and genome integrity over time, despite continuous
generation of mitochondrial mutations. Most notably, cells possess
mechanisms that enable the detection, segregation, and finally
mitophagic destruction of dysfunctional mitochondria, in a process
termed mitochondrial quality control. The importance of this quality
control in cell physiology is demonstrated by experiments showing that
mitophagy inhibition decreases bulk mitochondrial oxidative phospho-
rylation capacity and causes deficits in cell function (Twig et al., 2008).
As described above, IIS inhibits autophagy in general. This autophagy
inhibition leads to long-term declines in mitochondrial health: Long-term
Fig. 1 The insulin/insulin growth factor signaling pathway and its activation by
reactive oxygen species (ROS). Insulin or other growth factors bind to and activate
the insulin receptor or other receptor tyrosine kinases. This binding leads to PI3K
and Akt activation either directly or via Ras. Akt phosphorylates and inhibits the
activities of Foxo and the Tor inhibitor Tsc1/Tsc2. Activated Tor impairs autophagy
and activates protein synthesis, whereas activated Foxo has the opposite effects.
Phosphatases inhibit signaling either by catalyzing receptor dephosphorylation or
by antagonizing PI3K activity. Pathway activators are shown in blue, and inhibitors
in gray. ROS inhibits pathway inhibitors (red) and activates pathway activators
(green).
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(10-week) Tor activation in the heart increases mitochondrial number,
but decreases mitochondrial output, both phenotypes likely a conse-
quence of impaired mitophagy (Grevengoed et al., 2015). Furthermore,
IIS specifically inhibits transcription of the mitophagy inducer PINK1
(PTEN-induced Kinase 1), which was originally identified as a gene
transcriptionally upregulated by the IIS inhibitor PTEN (Unoki & Naka-
mura, 2001) (Fig. 1). This transcriptional induction is mediated by Foxo
(Mei et al., 2009; Sengupta et al., 2011). This mitophagy inhibition has
important physiological consequences, as mitophagy inhibition prevents
the lifespan-increasing effects of IIS inhibition in nematodes (Palikaras
et al., 2015). In addition, increasing mitophagy genetically or pharma-
cologically can extend lifespan in several organisms (Rana et al., 2013;
Ryu et al., 2016).
The observation that IIS inhibits autophagy and mitophagy in rapidly
growing cells, despite deleterious long-term consequences, suggests two
conclusions. First, that mitochondrial ATP production is limiting, partic-
ularly under high growth conditions, suggesting further that rapidly
growing cells operate under an ATP deficit. Protein synthesis requires a
large expenditure of ATP; the observation that Tor induces mitochondrial
protein translation to increase ATP production is consistent with this
view (Morita et al., 2013). Second, that mitophagy decreases ATP
production, at least in the short term; mitophagy requires several hours,
and during this time, the engulfed mitochondrion is not able to
contribute to ATP production. In this way, overzealous or precocious
removal of mostly functional mitochondria will decrease peak mito-
chondrial ATP production in the short term (Fig. 2).
Experiments performed in invertebrates support both of these
conclusions. Activation of mitophagy in nematodes decreases ATP levels
in young worms (Ryu et al., 2016), and increasing mitophagy by PINK1
overexpression in the Drosophila eye decreases eye size (Koh et al.,
2012). Similarly in Drosophila, ubiquitous expression of an activated, but
not wild-type, form of the mitophagy protein Parkin is lethal, and
muscle-specific expression of this activated Parkin decreases muscle
function in adults. This result suggests that excessive mitophagy can be
deleterious even in adulthood (Shiba-Fukushima et al., 2014). I suggest
that as damaged mitochondria accumulate during aging, organisms
become increasingly dependent on these mitochondria for necessary
ATP production. This increasing dependency, in fact, is what necessitates
the decreasing mitophagy during aging. Consistent with this view, the
effectiveness of decreased IIS on extending C. elegans lifespan progres-
sively diminishes as the decreased IIS is initiated progressively later during
aging (Dillin et al., 2002). I suggest that the abrupt increase in
mitophagy caused by late-in-life IIS inhibition leads to a deleterious
culling of damaged, but essential mitochondria.
Mitophagy inhibition as the cellular correlate of
antagonistic pleiotropy
An organism that slows its growth through excessive mitophagy will
allow out-competition for scarce nutrients by other organisms. Thus,
under rapid growth conditions, cells attain a short-term selective
advantage by inhibiting mitophagy. However, this mitophagy inhibition
also allows persistence of mitochondria with damaged DNA, which will
eventually lead to decreased mitochondrial ATP production as damaged
mitochondria accumulate. Accumulation of damaged mitochondria has
been proposed to promote aging (Dutta et al., 2012; Palikaras &
Tavernarakis, 2012; Carnio et al., 2014; Diot et al., 2016). Thus, cells
attain a long-term selective disadvantage by inhibiting mitophagy
(Fig. 2). The combination of short-term advantage and long-term
disadvantage suggests that mitophagy inhibition acts as a cellular
correlate with AP.
As mitophagy inhibition continues and mitochondrial dysfunction
increases, ATP output will decline, exacerbating the ATP deficit. I suggest
that as this ATP deficit increases, cells respond by further inhibiting
mitophagy in order to salvage higher ATP production. This response
eventually leads to a further decrease in mitochondrial ATP production, a
further increase in the ATP deficit, and so on, in a classic death spiral
(Fig. 2). Ultimately, a catastrophic collapse in ATP production ensues.
In this view, evolution selects for rapid growth as well as slow aging.
However, because of the specific biology of mitochondria, organisms
cannot simultaneously grow rapidly and age slowly. Organisms will
balance these contradictory alternatives to maximize lifetime reproduc-
tion. Different species may choose to emphasize either rapid growth or
slow aging, and evolutionary niches are available for many different
growth/aging strategies. The house mouse combines extremely rapid
growth (~20-day gestation period) with extremely rapid aging (~3-year
lifespan) and presumably low levels of mitophagy, whereas the naked
mole rat combines extremely slow growth (~70-day gestation period)
with extremely slow aging (~30-year lifespan; Roelling et al., 2011) and
presumably high levels of mitophagy. In addition, organisms are capable
of modulating growth rate vs. aging rate upon changes in nutrient
availability; this is accomplished by modulating IIS activity and hence
mitophagy (Kenyon, 2010). However, the trade-off between rapid
growth and slow aging is never eliminated.
A proposed mechanism for the mitochondrial death
spiral
As mitochondrial output begins to decline during aging, cellular demand
for ATP outstrips the ability of mitochondria to produce the required
ATP. I suggest that this inadequacy of ATP supply is communicated to
the cytoplasm by an increase in mitochondrial ROS production. For
example, mouse cardiac cells under metabolic load and Drosophila
muscle cells with genetically impaired complex I function increase ROS
generation (Sundaresan et al., 2009; Owusu-Ansah et al., 2013). Other
studies indicate increased ROS generation from mitochondria defective
in oxidative phosphorylation (Turrens, 2003; Kregel & Zhang, 2007;
Murphy, 2009, 2013; Tal et al., 2009; West et al., 2011; Raimundo
et al., 2012). Finally, mitophagy impairment is sufficient to increase ROS
generation in yeast (Kurihara et al., 2012; Bin-Umer et al., 2014) and
human monocytes (Zhou et al., 2011). How mitochondrial dysfunction
increases ROS generation is not clear. Taken together, these
Fig. 2 Short-term and long-term effects of impaired mitophagy. An ATP deficit
impairs mitophagy by activating IIS. This mitophagy impairment prevents
premature autophagic destruction of partially functional mitochondria. This
impairment increases ATP production and thus facilitates growth in the short term.
However, by allowing persistence of damaged mitochondria, this impairment leads
to the accumulation of dysfunctional mitochondria and decreased ATP production
in the long term. By combining short-term benefit and long-term detriment, I
suggest that impaired mitophagy underlies antagonistic pleiotropy.
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observations indicate that cells respond to initial declines in mitochon-
drial ATP production by increasing ROS generation, which I suggest
signals the cell that mitochondrial ATP output has become inadequate to
meet cellular requirements.
I suggest that this ROS increase inhibits mitophagy via IIS activation.
ROS has been shown to increase IIS pathway activity at several steps
(Fig. 1; Okoh et al., 2013; reviewed in Sullivan and Chandel, 2014). First,
several intermediates of IIS are activated by ROS either produced
endogenously or supplied exogenously. In particular, Ras is activated
when the thiol group of cysteine 118 is oxidized (Sawyer et al., 2002;
Kuster et al., 2005; Sundaresan et al., 2009). This mechanism might
underlie the observation that the activation of Erk by hydrogen peroxide
requires Ras activity (Guyton et al., 1996). In addition, hydrogen
peroxide activates PI3K (Wang et al., 2000; Qin & Chock, 2003; Stone
& Yang, 2006), and ROS directly activates Tor (Sarbassov & Sabatini,
2005; Reiling & Sabatini, 2006) in part by inducing disulfide bond
formation at the C-terminus, which stabilizes the protein (Dames et al.,
2005). Second, several IIS inhibitors are themselves inhibited by ROS.
PTP1B, a phosphatase that deactivates receptor tyrosine kinases, is
inhibited by oxidation, which enables activation of both the insulin and
epidermal growth factor receptors (Knebel et al., 1996; Denu & Tanner,
1998; Lee et al., 1998; Finkel & Holbrook, 2000). In addition, PTEN,
which removes the 3’ phosphate from PIP3 and thus opposes PI3K
activity, is likewise inhibited by ROS (Lee et al., 2002; Leslie et al., 2003;
Connor et al., 2005). Finally, ROS inhibits the Tsc1/Tsc2 complex,
thereby relieving Tor from upstream inhibition (Yoshida et al., 2011).
Thus, ROS acts through a variety of targets to activate IIS and Tor. This IIS
activation is predicted to inhibit Foxo.
Not only does increased ROS activate IIS, but activated IIS also
increases ROS (Irani et al., 1997; Trachootham et al., 2006; Nogueira
et al., 2008; Silva et al., 2011; reviewed in Dolado & Nebreda, 2008).
This increase in ROS likely occurs at least in part via mitophagy inhibition,
which as described above is sufficient to activate ROS, although
mitophagy-independent, IIS-dependent ROS increases might also occur.
The ability of IIS and ROS to activate each other supports the notion that
a ROS/IIS positive feedback can be generated. Such a positive feedback,
once initiated, is anticipated to progressively impair mitophagy, accel-
erate mitochondrial dysfunction, and irreversibly decrease cellular ATP
production.
Based on these molecular events, I propose the following model for
the mitochondrial death spiral (Fig. 3). As deficit of mitochondrial ATP
production continues to rise, the consequent rise in mitochondrial ROS
production progressively oxidizes the cytoplasm and increases IIS
pathway activity. Mitophagy thus becomes progressively attenuated,
further exacerbating mitochondrial decline and thus the ATP supply
deficit, in a positive feedback loop.
Testing predictions of this model
Mitochondrial dysfunction increases with age
Many lines of evidence indicate that mutations in mitochondrial DNA
accumulate and mitochondrial function declines during aging (reviewed
in Payne & Chinnery, 2015). Mitochondrial DNA damage increases in
aging rodents (Hamilton et al., 2001; Genova et al., 2004; Hagen et al.,
2004) and humans (Taylor et al., 2003), and these increases in mutation
can lead to reduced flow through the electron transport chain during
aging (Wanagat et al., 2001; Hagen et al., 2004; Short et al., 2005;
reviewed in Golden & Melov, 2001; Ikeda et al., 2014).
Cells become more oxidized with age
The model shown in Fig. 3 suggests that as the mitochondrial death
spiral progresses, cells should become progressively more oxidized. This
possibility is supported by investigations by several groups (reviewed in
Droge, 2003). In particular, older animals generate more oxidation
products than younger animals in response to radiation (Beckman &
Ames, 1998). In addition, levels of reduced glutathione decline with age
both in plasma and in multiple tissues (Maher, 2005; Jones, 2006),
perhaps as a consequence of age-dependent decreases in glucose 6
phosphate dehydrogenase activity (Beckman & Ames, 1998). Finally, it
was shown in yeast, nematodes, and Drosophila that the cytoplasm or
mitochondria become increasingly oxidized during aging (Liu et al.,
2012; Brandes et al., 2013; Kirstein et al., 2015; Knieß & Mayer, 2016).
This cellular oxidation might be responsible for the observation that very
old Drosophila display strikingly similar changes in gene expression to
Drosophila placed under oxidative stress (Landis et al., 2004).
ROS production increases with age
The increase in oxidation state during aging is most likely a consequence,
at least in part, of increased generation of ROS from mitochondria. In
Drosophila, hydrogen peroxide production significantly increases during
aging (Cocheme et al., 2011; Sohal & Orr, 2012; Orr et al., 2013) and
increased ROS release during aging was observed from rodent muscles,
heart, liver, and brain (Sohal et al., 1994; Bejma & Ji, 1999; Bejma et al.,
2000; Driver et al., 2000; Vasilaki et al., 2006; reviewed in Hekimi et al.,
2011).
IIS becomes more activated with age
Several lines of evidence suggest that Foxo activity diminishes during
aging in the rat muscle and kidney (Edstr€om et al., 2006; Kim et al.,
2008, 2014). In addition, the transcription of several autophagy genes
decreases during aging in the Drosophila flight muscle. This decrease is
mostly likely due to decreased Foxo activity, as ectopic overexpression of
Foxo is sufficient to rescue this transcriptional decrease (Demontis &
Perrimon, 2010). Finally, transcription of the Foxo-dependent mitophagy
gene PINK1 is downregulated during aging in the mouse lung (Sosulski
et al., 2015).
The effect of aging on Tor activity is less clear. Although Tor activity
was reported to increase with age in muscle, liver, lung, and stem cells
(Chen et al., 2009; Sandri et al., 2013; Leontieva et al., 2014; reviewed
by Nacarelli et al., 2015; Romero et al., 2016; White et al., 2016), other
Fig. 3 The mitochondrial death spiral. Cellular ATP deficit or mitochondrial
dysfunction causes increased production of ROS. This increased ROS activates IIS,
which in turn activates ROS by inhibiting mitophagy and thus promoting further
mitochondrial dysfunction and exacerbating the cellular ATP deficit. IIS might also
increase ROS through mitochondria-independent mechanisms.
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studies failed to confirm some of these findings (Baar et al., 2016). It
appears that phosphorylation of various Tor substrates is affected
differentially during aging. Unfortunately, phosphorylation status of
autophagy components is difficult to evaluate due to lack of phospho-
specific antibodies. In addition, Tor activity is less effective in regulating
autophagy when Foxo activity is low (Mammucari et al., 2007), most
likely because of the low expression of autophagy proteins.
Autophagy declines with age
Many lines of evidence demonstrate that autophagy declines with aging
(reviewed in Keller et al., 2004; Bergamini et al., 2004; Massey et al.,
2006; Cuervo, 2008; Rubinsztein et al., 2011; Kroemer, 2015; Romero
et al., 2016). Autophagy declines during normal aging in Drosophila
muscle (Demontis & Perrimon, 2010), rat liver (Del Roso et al., 2003);
mouse lung (Shirakabe et al., 2016), and human brain (Keller et al.,
2004; Lipinski et al., 2010). Finally, the mitophagy inducer PINK1 is
transcriptionally downregulated during aging in mouse lung (Sosulski
et al., 2015).
The declines in mitophagy during aging might be causally related to
declines in mitochondrial biogenesis also observed during aging (Vina
et al., 2009; Seo et al., 2010). Declines in mitochondrial biogenesis are
likely caused in part by decreased levels of transcription factors such as
PGC-1a and NRF1 that increase expression of mitochondrial genes
(Baker et al., 2006; Finley & Haigis, 2009). In addition, PGC-1a activity is
inhibited by Akt-dependent phosphorylation (Li et al., 2007), which
might link the observed increase in IIS during aging with attenuated
mitochondrial biogenesis. Thus, cells combine attenuated mitophagy
with attenuated mitochondrial biogenesis, which enables total mito-
chondrial mass to be held within controlled limits.
Greatly elevated cytoplasmic oxidation late in life:
implications for oxidative stress, mitohormesis, and
insulin resistance
Different levels of ROS confer distinct cellular effects. Low levels of ROS
induce growth, protein synthesis, and proliferation (Antunes & Cadenas,
2001; Kwon et al., 2003; Cadenas, 2004). I suggest that these ROS
levels are generated as the mitochondrial death spiral progresses. In
contrast, higher ROS levels can induce an oxidative stress response that
involves JNK activation and Tor inhibition (Reiling & Sabatini, 2006;
Takimoto and Kass, 2007). Activated JNK, in turn, activates Foxo by
phosphorylation, which overcomes the Foxo nuclear import barrier
induced by IIS (Oh et al., 2005; Tzivion et al., 2011) and enables Foxo
activity despite Akt-dependent phosphorylation (Wang et al., 2005). This
Foxo activation is necessary for activated JNK to increase lifespan (Wang
et al., 2005). Although the mechanism underlying the Tor inhibition that
occurs under high ROS is not completely clear, it is possible that a role is
played by the ROS-dependent activation of AMPK (Cardaci et al., 2012),
which inhibits Tor both by phosphorylating and activating the Tor
inhibitor Tsc1/Tsc2 (Fig. 1; Inoki et al., 2003) and by phosphorylating
and inhibiting the Tor-associated scaffold Raptor (Gwinn et al., 2008).
JNK is activated during aging in the rodent brain and liver and in the gut
of very old Drosophila (Suh, 2001; Hsieh et al., 2003; Williamson et al.,
2003; Biteau et al., 2008; Zhou et al., 2009); this gut JNK activation is at
least partly responsible for the Foxo activation that occurs in these very
old Drosophila (Guo et al., 2014). Taken together, these results raise the
possibility that very late in life, the cytoplasm can become oxidized
sufficiently to induce an oxidative stress response that reactivates Foxo
and inhibits Tor. These late-stage effects on Foxo and Tor are predicted
to induce a cellular switch to mitochondrial protection late in life.
Mitochondrial protection triggered by oxidative stress is termed ‘mito-
hormesis’ (Tapia, 2006).
I suggest that induction of mitohormesis by high ROS production
explains at least in part the well-established observation that pharma-
cologically or genetically crippling ATP production is capable of
increasing lifespan (Lee et al., 2003; Schulz et al., 2007; Copeland
et al., 2009; Owusu-Ansah et al., 2013; Sun et al., 2014). For example,
Owusu-Ansah et al. (2013) reported that the increased lifespan caused
by knockdown of the complex I subunit ND75 is accompanied by, and
requires, a ROS increase, followed by JNK activation, transcriptional
induction of several Foxo target genes, including 4E-BP, InR, and ImpL2,
and increased mitophagy (Owusu-Ansah et al., 2013). In addition,
Schulz et al. (2007) reported that impaired glycolysis extended lifespan
by the ROS-dependent activation of AMPK (Schulz et al., 2007). In a
similar manner, feeding superoxide generators can increase lifespan in
C. elegans (Yang & Hekimi, 2010). This lifespan increase requires Foxo
(Heidler et al., 2010) and thus might be due to JNK-dependent
mitohormesis as well. Taken together, these results indicate that high
ROS levels, beginning early in life, enable cells to bypass the mitochon-
drial death spiral and proceed directly to the late-stage mitohormetic
state, and that this phenomenon is responsible for the increased lifespan
observed.
Furthermore, cytoplasmic oxidation sufficient to promote an oxidative
stress response might also be relevant to understanding the insulin
resistance (IR) that often develops in the elderly. Oxidative stress and JNK
are implicated in IR (Salmon, 2012); JNK phosphorylates the insulin
receptor substrate 1 (IRS-1) and attenuates the ability of ligand-bound
insulin receptor to activate IRS-1 (Aguirre et al., 2000). A JNK deletion at
least partly restores insulin sensitivity in a mouse obesity model (Hirosumi
et al., 2002), indicating that this JNK-dependent phosphorylation is
functionally relevant. Given the observation that oxidative stress is
increased during aging (Mendoza-Nu~nez et al., 2011), these results
suggest that age-dependent IR, like the late-stage mitohormetic state,
occurs at least in part when the mitochondrial death spiral-induced
cytoplasmic oxidation progresses sufficiently to activate JNK.
Increased ROS also promotes mitochondrial protection through
activation of the transcription factor Nrf2, which triggers expression of
a number of antioxidant genes (Ristow & Schmeisser, 2014). Increased
expression of antioxidants is expected to attenuate the ROS-mediated
positive feedback (Fig. 3), and the observation that Nrf2 activity shows
dose-dependent effects on lifespan (An et al., 2005) is consistent with
this attenuation. However, Nrf2 activity declines with age (Suh et al.,
2004), which likely occurs at least in part by increased Tor-dependent
inhibition of Nrf2 activity (Robida-Stubbs et al., 2012; Lerner et al.,
2013). Loss of Nrf2 activity with age will thus weaken the ability of Nrf2
to attenuate the positive feedback and might play a part in permitting
the positive feedback shown in Fig. 3 to accelerate during aging.
Role of antioxidants in lifespan
The hypothesis proposed here predicts that antioxidant administration, if
applied before the mitohormetic state develops, should extend lifespan.
However, data on the effects of antioxidant administration have been
difficult to interpret. Although ectopic overexpression of the peroxire-
doxin Prx5 increases lifespan in Drosophila (Radyuk et al., 2009),
indicating that decreasing ROS production can attenuate the mitochon-
drial death spiral as expected, the effects of feeding antioxidants on
lifespan have been inconsistent. Difficulties in enabling antioxidant
access to the cytoplasm might represent one issue, as the effectiveness
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of specific antioxidants can vary depending on the precise method of
antioxidant presentation (Shibamura et al., 2009; in data interpretation
include the difficulty in determining the Desjardins et al., 2016).
Additional difficulties extent to which the antioxidant feeding actually
reduces the cytoplasm. Fluorescent ROS indicators that monitor light
production from the whole organism are problematic as these combine
signal from the various subcellular and extracellular compartments,
including the cytoplasm, mitochondria, peroxisomes, ER, and extracel-
lular space, which all possess different redox states. This complicates
ability to isolate redox changes specific to the cytoplasm. In addition, it is
often difficult to distinguish lifespan effects due to antioxidant properties
from beneficial or toxic effects of the compounds distinct from
antioxidant properties. From these results, I suggest that the ability of
antioxidants to increase lifespan remains an unresolved question.
Future work and limitations and extensions of this
model
Causality has not yet been determined for several proposed events. Thus,
for example, it is not yet known whether the increased oxidation state of
the aging cytoplasm is causal for increased IIS. Further studies will be
needed to address this issue. Second, this analysis deals specifically with
only one mechanism proposed to underlie AP. It is likely that AP is also
driven by other mechanisms. In addition, it is also likely that processes
independent of AP drive aging. Such non-AP aging processes could arise
as a consequence of decreased selective pressure in old age. Finally, the
ROS-IIS positive feedback system described here is likely to advance
aging through processes in addition to loss of mitochondrial ATP
production. For example, the age-dependent activation of Tor and loss
of Foxo described above are predicted to inhibit autophagy in general.
This progressive loss of autophagy, combined with increased ROS and
thus ROS-mediated oxidative damage, might be responsible in part for
the loss of proteostasis that occurs during aging and likely plays a critical
role in the aging process. This loss of proteostasis is manifested by the
accumulation of protein aggregates, inclusion bodies, and other
damaged macromolecules, which are degraded via autophagy (Yao,
2010). The possibility that Tor activation during aging might be partly
responsible for the accumulation of these damaged macromolecules has
led to the suggestion that rapamycin administration might be helpful in
reversing this accumulation. In addition, Foxo plays a critical role in
inducing expression of components of the proteasome as well as
components of the autophagosome (Webb & Brunet, 2014). Thus, loss
of Foxo activity during aging is likely to contribute to loss of proteostasis
through multiple outputs.
You cannot get there from here
The mitochondrial death spiral should not be viewed as an error in cell
physiology. Rather, this death spiral should be viewed as a deliberate,
sensible, in fact necessary, approach by cells to solve the difficult
problem of successfully growing and reproducing in a competitive world
of scarce nutrients. This problem is exacerbated by the fact that cells
have not yet been able to relocate every mitochondrial gene to the
nucleus. This deficit means that the simultaneous demand for both high
ATP production and high mitochondrial quality control becomes
contradictory. The mitochondrial death spiral represents a cellular
attempt to resolve these contradictory demands.
It might seem plausible to dispose of the mitochondrial death spiral
after growth and reproduction are complete. Thus, when very high
levels of ATP production are no longer needed, perhaps an aging cell
could rejuvenate by greatly amplifying the few pristine mitochondria
that might remain and degrading the rest. However, in practice, this
course of action might require as a temporary intermediate a lethal
decline in ATP production. Extrication from a death spiral once
initiated is not easy. If a path from one point to another requires
transit through a lethal state, then this path cannot be taken,
regardless of the attractiveness of the destination (see John Maynard
Keynes’ quote above). Evolution has not found a way to overcome
this drawback. That is not to say that this problem is intractable.
Perhaps this problem could be solved by organisms possibly more
ingenious and certainly more motivated than evolution.
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